Canadian guidelines for post COVID-19 condition (CAN-PCC): A summary for general practitioners
Open Access
- 13 October 2026
- journal article
- Published by Taylor & Francis in European Journal of General Practice
- Vol. 32 (1)
Abstract
No abstract availableFunding Information
- Public Health Agency of Canada and Canadian Institute for Health Research (202503FOB)
This publication has 23 references indexed in Scilit:
- Global Prevalence of Long COVID, Its Subtypes, and Risk Factors: An Updated Systematic Review and Meta-analysisOpen Forum Infectious Diseases, 2025
- Long COVID: Pathophysiology, current concepts, and future directionsJournal of Allergy and Clinical Immunology, 2024
- Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19New England Journal of Medicine, 2024
- A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trialThe Lancet Infectious Diseases, 2023
- Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trialThe Lancet Infectious Diseases, 2023
- Risk Factors Associated With Post−COVID-19 ConditionJAMA Internal Medicine, 2023
- Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 ConditionJAMA Internal Medicine, 2023
- Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsThe Lancet Respiratory Medicine, 2023
- GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENTJournal of Clinical Epidemiology, 2017
- Pyridostigmine Treatment Trial in Neurogenic Orthostatic HypotensionArchives of Neurology, 2006